Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 90 days matching "cell-free dna"

GrantNIH REPORTERMay 11

New NIH Grant: Programmable Multiplexed Detection of Cell-free DNA Mutation for Liquid Biopsy — $415K at Unknown Institution

Researchers are developing a new blood test that can detect tiny pieces of cancer DNA floating in the bloodstream to catch lung cancer early. Instead of invasive procedures like biopsies or CT scans, this simple blood test could help doctors find lung cancer sooner and monitor how well treatment is working. The National Institutes of Health is funding this $415,000 research project starting in 2026.

WHY IT MATTERSFor lung cancer patients, this blood-based test could enable earlier detection when treatment is most effective and reduce the need for invasive biopsies or repeated imaging scans.
👁 Watch this spacelung cancer

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases